Two Sigma Investments, LP Repligen Corp Call Options Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $1.68 Million - $2.07 Million
6,800 Added 154.55%
11,200 $2.97 Million
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $58,431 - $97,263
300 Added 7.32%
4,400 $1.27 Million
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $331,740 - $441,900
2,000 Added 95.24%
4,100 $818,000
Q1 2021

May 17, 2021
SELL
$180.37 - $226.26 $36,074 - $45,252
-200 Reduced 8.7%
2,100 $408,000
Q3 2020

Nov 16, 2020
BUY
$122.51 - $158.27 $281,773 - $364,021
2,300 New
2,300 $339,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email